Latest News for: pharmaceutical company

Edit

Global Pharmaceutical Intermediates Market Poised for Steady Growth, Projected to Reach USD 57,031.9 million by 2035

Pharmiweb 19 Feb 2025
Pharmaceutical companies are increasingly outsourcing intermediate production to enhance scalability and cost-effectiveness ... Partnerships between pharmaceutical companies and CMOs/CDMOs are fostering innovation and streamlining supply chains.
Edit

Cystinosis Market Analysis 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Prevalence, Treatment Market, Medication, Revenue, ...

GetNews 19 Feb 2025
Cystinosis Companies working in the treatment market are Horizon Pharmaceutical/Chiesi Farmaceutici, Recordati S.p.A, Nacuity Pharmaceuticals, Inc., Nacuity Pharmaceuticals, Avrobio, and others ... Nacuity Pharmaceuticals, Inc ... Company Name.
Edit

Trump plans to impose 25% tariffs on autos, chips and pharmaceuticals

CNN 19 Feb 2025
President Donald Trump said on Tuesday that he plans to impose tariffs of around 25% on auto imports as well as semiconductors and pharmaceuticals shipped to the United States as early as April 2.
Edit

Ludlow cancer group eco-drive over medicine blister packs

BBC News 19 Feb 2025
"Should we all be writing to our MP asking for the pharmaceutical companies to take responsibility," she asked ... "Should we be putting pressure on the pharmaceutical companies to say to ...
Edit

Indian pharma stocks fall after Donald Trump plans 25% tariff

Hindustan Times 19 Feb 2025
An index of Indian pharmaceutical company shares slid 2% to its lowest level in seven months on Wednesday after U.S ... Trump's tariff plans are making investors jittery at the moment, as most of these companies rely on the U.S.
Edit

Hemophilia B Market Analysis 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Pipeline, NDA Approvals, ...

GetNews 19 Feb 2025
Hemophilia B Companies working in the treatment market are Centessa Pharmaceuticals, Sanofi (Genzyme)/Alnylam Pharmaceuticals, Pfizer/ Spark Therapeutics, Novo Nordisk, and others.
Edit

Hepatic encephalopathy Market Analysis 2034: Prevalence, EMA, PDMA, FDA Approvals, Clinical Trials, Medication, Pipeline, Epidemiology, ...

GetNews 19 Feb 2025
Hepatic Encephalopathy Companies working in the market are Vedanta Biosciences, Salix Pharmaceuticals, Bausch Health, Axcella Health, Inc., Umecrine Cognition, Patricia Bloom, Rebiotix, and others ... Key Hepatic Encephalopathy Companies ... Company Name.
Edit

Karyopharm Therapeutics: Q4 Earnings Snapshot

The Call 19 Feb 2025
On a per-share basis, the Newton, Massachusetts-based company said it had a loss of 24 cents ... The pharmaceutical company posted revenue of $30.5 million in the period.
Edit

Head and Neck Squamous Cell Carcinoma Market Analysis 2032: Clinical Trials, EMA, PDMA, FDA Approvals, ...

GetNews 19 Feb 2025
Head and neck squamous cell carcinoma companies are ... The need for extensive patient recruitment, complex trial designs, and long-term follow-ups adds to the financial burden on pharmaceutical companies.
Edit

Mysterious Drug Pricing Needs a Dose of Sunshine

Oelwein Daily Register 19 Feb 2025
Then, they evolved into an intermediary between pharmaceutical companies, pharmacies and third-party payers, including health insurance companies, self-insured employers, unions and government programs.
Edit

Inside Trump’s Lucrative Dinners With Healthcare Execs

Political Wire 19 Feb 2025
First came the pharmaceutical executives,” the Wall Street Journal reports. “Then the insurance companies and the hospital leaders ... Robert F. Kennedy Jr.
Edit

De-ratings accelerate after Q3 earnings. IndusInd Bank among Nuvama’s top 10 downgrades

The Economic Times 19 Feb 2025
Key downgrades include companies from various sectors such as ...
×